Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

Paolo Lanzetta, Jean‐François Korobelnik, Jeffrey S. Heier, Sérgio Leal, Frank G. Holz, W. Lloyd Clark, David Eichenbaum, Tomohiro Iida, Xiaodong Sun, Alyson J. Berliner, Andrea Schulze, Thomas Schmelter, Ursula Schmidt-Ott, Xin Zhang, Robert Vitti, Karen Chu, Kimberly Reed, Rohini Rao, Rafia Bhore, Yenchieh Cheng, Wei Sun, Boaz Hirshberg, George D. Yancopoulos, Tien Yin Wong